Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer

Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society
T HirataKeiji Miyata


In this study, we examined the effects of serotonin (5-HT)3 receptor antagonists (5-HT3RAs) including ramosetron, alosetron, and cilansetron on colonic nociceptive threshold in rats. Furthermore, we established a restraint stress-induced colonic hyperalgesia model in rats, and compared the inhibitory effects of 5-HT3RAs on restraint stress-induced colonic hyperalgesia and diarrhoea with those of loperamide, trimebutine, tiquizium and polycarbophil. The colonic nociceptive threshold was measured as the balloon pressure at the time the rat showed a nociceptive response during colonic distension by an intrarectally inserted balloon. Oral administration of ramosetron (3-30 microg kg(-1)), alosetron (30-300 microg kg(-1)), or cilansetron (30-300 microg kg(-1)) increased the colonic nociceptive threshold in a dose-dependent manner in non-stressed rats. Restraint stress for 1 h significantly decreased the colonic nociceptive threshold, but ramosetron (0.3-3 microg kg(-1)), alosetron (3-30 microg kg(-1)), cilansetron (3-30 microg kg(-1)) and trimebutine (100-1000 mg kg(-1)) significantly inhibited the decrease in the threshold. Loperamide (3-30 mg kg(-1)), tiquizium (100-1000 mg kg(-1)) and polycarbophil (1000 mg kg(-1)) did not affect...Continue Reading


May 1, 1987·The Journal of Pharmacy and Pharmacology·F RomanJ L Junien
Jan 1, 1995·British Journal of Pharmacology·S E Banner, G J Sanger
Jul 1, 1994·Gastroenterology·E A Mayer, G F Gebhart
Jun 1, 1993·Digestive Diseases and Sciences·F AwoutersP A Janssen
Mar 26, 1997·European Journal of Pharmacology·M SchäferC Stein
Feb 7, 1998·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M GuéL Buéno
Feb 24, 2001·Alimentary Pharmacology & Therapeutics·T PoynardY Benhamou
Jul 18, 2002·Japanese Journal of Pharmacology·Takaharu SaitoHideo Kato
Aug 28, 2002·The Journal of Pharmacy and Pharmacology·Chika YamamotoYasufumi Sawada
Nov 12, 2002·The American Journal of Gastroenterology·Lawrence J BrandtNicholas Talley
Dec 17, 2002·Current Opinion in Pharmacology·L A Blackshaw, G F Gebhart
Apr 22, 2004·British Journal of Pharmacology·Michael D Crowell
Sep 11, 2004·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J D Wood, J J Galligan
Aug 9, 2005·The Journal of Pain : Official Journal of the American Pain Society·G Nicholas VerneDonald D Price
May 9, 2006·Gastroenterology·George F LongstrethRobin C Spiller
Feb 27, 2007·Inflammopharmacology·T HirataM Sasamata
Jul 27, 2007·Journal of Pharmacological Sciences·Takuya HirataMasao Sasamata

❮ Previous
Next ❯


Aug 10, 2010·Current Gastroenterology Reports·Noriaki ManabeMichael Camilleri
Nov 19, 2008·Molecular Interventions·David R Robinson, G F Gebhart
Oct 3, 2013·The Journal of Clinical Investigation·Michael Camilleri
Oct 24, 2013·World Journal of Gastroenterology : WJG·Hiroki MoritaHiroyuki Kuwano
Jan 26, 2013·Journal of Neurogastroenterology and Motility·Yoo Mi ParkHyojin Park
Apr 30, 2013·Expert Opinion on Pharmacotherapy·Michael Camilleri
Dec 30, 2014·Journal of Neurogastroenterology and Motility·Bruno K Rodiño-JaneiroJavier Santos
May 8, 2015·Therapeutic Advances in Gastroenterology·Yang Won Min, Poong-Lyul Rhee
Aug 3, 2018·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Y KawaharaS Katsumata
Sep 30, 2009·Alimentary Pharmacology & Therapeutics·M Camilleri
Jan 28, 2016·Nanoscale Research Letters·Xingliang XuZhiming M Wang
Nov 14, 2012·Nature Reviews. Gastroenterology & Hepatology·Magnus Halland, Nicholas J Talley
May 3, 2014·Biological & Pharmaceutical Bulletin·Tatsuya MutoYoshihiro Hotta
Apr 23, 2014·British Journal of Pharmacology·Christina J PerryAndrew J Lawrence
May 29, 2014·British Journal of Pharmacology·B Jupp, J W Dalley
Nov 12, 2009·Pharmacological Reports : PR·Małgorzata Filip, Michael Bader
Feb 24, 2012·Pharmacological Reports : PR·Joanna MiszkielEdmund Przegaliński
Jan 24, 2020·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Yasuo ItomiYasuhiro Tsukimi
Sep 17, 2011·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·K J LeeP L Rhee
Nov 28, 2015·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·S LiuA Bhargava
May 18, 2021·Journal of Equine Veterinary Science·Alshimaa M M Farag, Hussam M M Ibrahim
Sep 19, 2020·European Journal of Pharmacology·Tsukasa NozuToshikatsu Okumura
May 29, 2018·Journal of Ethnopharmacology·Francisco Felipe BezerraAna Lúcia Ponte Freitas

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.